维普期刊资源整合服务平台（V6.5）

25篇 您的检索式：作者名="Padrini"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Convective and adsorptiveremoval of beta 2-microglobulin during predilutional andpostdilutional hemofiltration显示文摘	Padrini R Canova C Conz P	2005	Kidney Int2005，68，5：	1
2	Phar-macokinetics of intraperitoneeal hyperthermic perfusion with mitoxantrone in orarian caner显示文摘	Nicoletto MO Di Filippo F Padrini R		0，，06：	1
3	VKORC1, CYP2C9 and CYP4F2 genetic-based algorithm for warfarin dosing: an Italian retrospective study显示文摘	Zambon CF Pengo V Padrini R	2011	Pharmacogenomics2011，12，1：	1
4	Convective and adsorptive removal of beta2-microglobulin during predilutional and postdilutional hemofiltration显示文摘	Padrini R Canova C Conz P		0，，：	1
5	Pharmacokinetics of intraperitoneal hyerthermic perfusion with mitoxantrone in ovarian cancer显示文摘	Nicoletto MO Padrini R Galeotti F	2000	Cancer Chemother Pharmacol2000，45，6：	1
6	Apolipoprotein E (APOE) and warfarin dosing in an Italian population显示文摘	Kohnke H Scordo MG Pengo V Padrini R Wadelius M	2005	Clin Pharmacol J2005，61，：	1
7	Pharmacokinetics of intraperitoneal hyperthennic perfusion with mitoxantrone in ovarian cancer显示文摘	Nicoletto MO Padrini R Galeotti F	2000	Cancer Chemother Pharmacol2000，45，6：	1
8	Related Articles, Links Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis显示文摘	Orlando R Mussap M Plebani M Piccoli P De Martin S Floreani M Padrini R Palatini P	2002	Clin Chem2002，48，6：	1
9	Intralesional topotecan in advanced ovarian cancer: a clinical report, based on a preclinical study 显示文摘	Nicoletto MO Padrini R Palumbo M	2002	Oncol Rep2002，9，6：	1
10	Distortionary Taxation and Labor Market Performance 显示文摘	Fiorito R Padrini F	2001	Oxford Bulletin of Economics and Statistics2001，63，2：	1
11	Convective and adsorp- tive removal of beta 2 microglobulin during predilutional and postdilutional hemofiltration显示文摘	Padrini R Canova C Conz P	2005	Kidney Int2005，68，5：	1
12	Pharmacokinetics of intmperitoneal hyperthermic perfusion with mitoxantrone in ovarian cancer显示文摘	Nicoletto MO Padrini R Galeotti F	2000	Cancer Chemother Pharmacol2000，45，6：	1
13	Pharmaeokinetics of intraperitoneal hyperthermie perfusion with mitoxan tronein ovarian cancer显示文摘	Nieoletto MO Padrini R Galeotti F	2000	Cancer Chemother Pharmacol2000，45，6：	1
14	Cytochrome P450 1A2 is a major determinant of lidocaine metabolism in vivo: effects of liver function 显示文摘	Piccoli P De Martin S Padrini R Floreani M Palatini P	2004	Clin Pharmacol Ther2004，75，1：	1
15	G > C SNP of thymidylate synthase with respect to colorectal cancer显示文摘	Gusella M Padrini R	2007	Pharmacogenomics2007，8，8：	1
16	Convective and adsorptive removal of beta 2 microglobulin during predilutional and postdilutional hemofiltration 显示文摘	Padrini R Canova C Conz P	2005	Kidney Int2005，68，5：	1
17	G > C SNP of thymidylate synthase with respect to colorectal cancer 显示文摘	Milena Gusellal Roberto Padrini	2007	Pharmacogenomics2007，8，8：	1
18	Pharmacokinetics of intraperitoneal hyperthermic perfusion with mitoxantrone in ovarian cancer显示文摘	M O Nicoletto R Padrini F Galeotti	2000	Cancer Chemother Pharmacol2000，45，：	1
19	Intralesional topotecan in advanced ovarian cancer:a clinical report,based on a preclinical study显示文摘	Nicoletto MO Padrini R Palumbo M	2002	Oncol Rep2002，9，：	1
20	VKORC1, CYP2C9 and CYP4F2 genetic - based algorithm for warfarin dosing: an Italian retrospective study 显示文摘	ZAMBON CF PENGO V PADRINI R	2011	Pharmacogenomics2011，12，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示